274 related articles for article (PubMed ID: 23845716)
21. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.
Silva M; Pastorino U; Sverzellati N
Clin Radiol; 2017 May; 72(5):389-400. PubMed ID: 28168954
[TBL] [Abstract][Full Text] [Related]
22. Quantification of growth patterns of screen-detected lung cancers: The NELSON study.
Heuvelmans MA; Vliegenthart R; de Koning HJ; Groen HJM; van Putten MJAM; Yousaf-Khan U; Weenink C; Nackaerts K; de Jong PA; Oudkerk M
Lung Cancer; 2017 Jun; 108():48-54. PubMed ID: 28625647
[TBL] [Abstract][Full Text] [Related]
23. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
de Koning HJ; van der Aalst CM; de Jong PA; Scholten ET; Nackaerts K; Heuvelmans MA; Lammers JJ; Weenink C; Yousaf-Khan U; Horeweg N; van 't Westeinde S; Prokop M; Mali WP; Mohamed Hoesein FAA; van Ooijen PMA; Aerts JGJV; den Bakker MA; Thunnissen E; Verschakelen J; Vliegenthart R; Walter JE; Ten Haaf K; Groen HJM; Oudkerk M
N Engl J Med; 2020 Feb; 382(6):503-513. PubMed ID: 31995683
[TBL] [Abstract][Full Text] [Related]
24. Lung cancer screening: Current status and perspective.
Chassagnon G; Revel MP
Diagn Interv Imaging; 2016 Oct; 97(10):949-953. PubMed ID: 27527243
[TBL] [Abstract][Full Text] [Related]
25. Results of the two incidence screenings in the National Lung Screening Trial.
Aberle DR; DeMello S; Berg CD; Black WC; Brewer B; Church TR; Clingan KL; Duan F; Fagerstrom RM; Gareen IF; Gatsonis CA; Gierada DS; Jain A; Jones GC; Mahon I; Marcus PM; Rathmell JM; Sicks J;
N Engl J Med; 2013 Sep; 369(10):920-31. PubMed ID: 24004119
[TBL] [Abstract][Full Text] [Related]
26. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Lammers JW; van Ooijen P; Nackaerts K; Weenink C; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H
Thorax; 2017 Jan; 72(1):48-56. PubMed ID: 27364640
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of automated lung nodule detection on low-dose computed tomography scans from a lung cancer screening program(1).
Armato SG; Roy AS; Macmahon H; Li F; Doi K; Sone S; Altman MB
Acad Radiol; 2005 Mar; 12(3):337-46. PubMed ID: 15766694
[TBL] [Abstract][Full Text] [Related]
28. Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules.
Markowitz SB; Miller A; Miller J; Manowitz A; Kieding S; Sider L; Morabia A
Chest; 2007 Apr; 131(4):1028-34. PubMed ID: 17426206
[TBL] [Abstract][Full Text] [Related]
29. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.
Saghir Z; Dirksen A; Ashraf H; Bach KS; Brodersen J; Clementsen PF; Døssing M; Hansen H; Kofoed KF; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thorsen H; Tønnesen P; Pedersen JH
Thorax; 2012 Apr; 67(4):296-301. PubMed ID: 22286927
[TBL] [Abstract][Full Text] [Related]
30. Low-dose CT: a useful and accessible tool for the early diagnosis of lung cancer in selected populations.
Callol L; Roig F; Cuevas A; de Granda JI; Villegas F; Jareño J; Arias E; Albiach JM
Lung Cancer; 2007 May; 56(2):217-21. PubMed ID: 17316889
[TBL] [Abstract][Full Text] [Related]
31. [Results of Lung Cancer Screening among Urban Residents in Kunming].
Lin Y; Ma J; Feng J; Zhang Q; Huang Y
Zhongguo Fei Ai Za Zhi; 2019 Jul; 22(7):413-418. PubMed ID: 31315779
[TBL] [Abstract][Full Text] [Related]
32. Can lung cancer screening by computed tomography be effective in areas with endemic histoplasmosis?
Starnes SL; Reed MF; Meyer CA; Shipley RT; Jazieh AR; Pina EM; Redmond K; Huffman LC; Pandalai PK; Howington JA
J Thorac Cardiovasc Surg; 2011 Mar; 141(3):688-93. PubMed ID: 20933243
[TBL] [Abstract][Full Text] [Related]
33. [Lung cancer screening with low dose CT requires careful consideration].
Saghir Z; Dirksen A; Ashraf H; Bach KS; Brodersen J; Clementsen PF; Døssing M; Hansen H; Kofoed KF; Larsen KR; Mortensen J; Rasmussen JF; Thomsen LH; Wille MM; Seersholm N; Skov BG; Thorsen H; Tønnesen P; Pedersen JH
Ugeskr Laeger; 2014 Oct; 176(42):. PubMed ID: 25316363
[TBL] [Abstract][Full Text] [Related]
34. Nodule management protocol of the NELSON randomised lung cancer screening trial.
Xu DM; Gietema H; de Koning H; Vernhout R; Nackaerts K; Prokop M; Weenink C; Lammers JW; Groen H; Oudkerk M; van Klaveren R
Lung Cancer; 2006 Nov; 54(2):177-84. PubMed ID: 16989922
[TBL] [Abstract][Full Text] [Related]
35. Lung cancer risk prediction to select smokers for screening CT--a model based on the Italian COSMOS trial.
Maisonneuve P; Bagnardi V; Bellomi M; Spaggiari L; Pelosi G; Rampinelli C; Bertolotti R; Rotmensz N; Field JK; Decensi A; Veronesi G
Cancer Prev Res (Phila); 2011 Nov; 4(11):1778-89. PubMed ID: 21813406
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography.
Sone S; Nakayama T; Honda T; Tsushima K; Li F; Haniuda M; Takahashi Y; Suzuki T; Yamanda T; Kondo R; Hanaoka T; Takayama F; Kubo K; Fushimi H
Lung Cancer; 2007 Dec; 58(3):329-41. PubMed ID: 17675180
[TBL] [Abstract][Full Text] [Related]
37. Early lung cancer detection using spiral computed tomography and positron emission tomography.
Bastarrika G; García-Velloso MJ; Lozano MD; Montes U; Torre W; Spiteri N; Campo A; Seijo L; Alcaide AB; Pueyo J; Cano D; Vivas I; Cosín O; Domínguez P; Serra P; Richter JA; Montuenga L; Zulueta JJ
Am J Respir Crit Care Med; 2005 Jun; 171(12):1378-83. PubMed ID: 15790860
[TBL] [Abstract][Full Text] [Related]
38. New Fissure-Attached Nodules in Lung Cancer Screening: A Brief Report From The NELSON Study.
Han D; Heuvelmans MA; van der Aalst CM; van Smoorenburg LH; Dorrius MD; Rook M; Nackaerts K; Walter JE; Groen HJM; Vliegenthart R; de Koning HJ; Oudkerk M
J Thorac Oncol; 2020 Jan; 15(1):125-129. PubMed ID: 31606605
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
[TBL] [Abstract][Full Text] [Related]
40. Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study.
Carozzi FM; Bisanzi S; Carrozzi L; Falaschi F; Lopes Pegna A; Mascalchi M; Picozzi G; Peluso M; Sani C; Greco L; Ocello C; Paci E;
Int J Cancer; 2017 Jul; 141(1):94-101. PubMed ID: 28387927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
